Lonza to acquire Capsugel in USD5.5bn deal

16 December 2016 - Deborah Wilkes

Archived

Switzerland's Lonza Group is acquiring the drug-delivery specialist Capsugel from private-equity firm KKR in a deal worth USD5.5 billion in cash, including refinancing of existing Capsugel debt of USD2.0 billion.

Click tags below for more information on topics:

Lonza

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: